Stroke prevention or bleeding: how to weigh the results of clinical trials

Back

EHRA Premium Access

Stroke prevention or bleeding: how to weigh the results of clinical trials

Session: Novel insights of LAA treatment for atrial fibrillation and stroke prevention

Topic: Stroke – Clinical

Speaker: Professor L. Boersma (Nieuwegein, NL)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Lucas Boersma

St Antonius Hospital, Nieuwegein (Netherlands (The))

39 presentations

4 followers

5 more presentations in this session

This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.

Access

Slides

Video

The role of the LAA for AF and stroke: fact or fiction

Speaker: Professor T. Lewalter (Munich, DE)

Access

Slides

Video

LAA closure concomitant to AF ablation - The surgical perspective

Speaker: Associate Professor S. Salzberg (Zurich, CH)

Access

Slides

Video

LAA closure concomitant to AF ablation - The EP perspective

Speaker: Professor C. Tondo (Monzino, IT)

Access

Slides

Video

New strategies for anticoagulation therapy after LAA closure

Speaker: Professor M. Glikson (Jerusalem, IL)

Access

Slides

Video

Access the full session

Novel insights of LAA treatment for atrial fibrillation and stroke prevention

Speakers: Professor L. Boersma, Professor T. Lewalter, Associate Professor S. Salzberg, Professor C. Tondo, Professor M. Glikson

Access

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources